Showing results (31-40 of 196) with videos related to
Sort By:
Pageof 20
Clinical Trials (London, England)|December 19, 2023
Risk-benefit trade-offs and precision utilities in phase I-II clinical trialsPavlos Msaouel, Juhee Lee, Peter F ThallBayesian Analysis|July 16, 2021
A Phase I-II Basket Trial Design to Optimize Dose-Schedule Regimes Based on Delayed OutcomesRuitao Lin, Peter F Thall, Ying YuanApplied Stochastic Models in Business and Industry|December 5, 2017
Clinical Trial Design as a Decision ProblemPeter Müller, Yanxun Xu, Peter F ThallStatistics & Probability Letters|July 30, 2014
A Modified Adaptive Lasso for Identifying Interactions in the Cox Model with the Heredity ConstraintLu Wang, Jincheng Shen, Peter F ThallBayesian Analysis|November 1, 2013
Prior Effective Sample Size in Conditionally Independent Hierarchical ModelsSatoshi Morita, Peter F Thall, Peter MüllerCancers|July 2, 2021
Making Patient-Specific Treatment Decisions Using Prognostic Variables and Utilities of Clinical OutcomesPavlos Msaouel, Juhee Lee, Peter F ThallStatistics in Medicine|April 8, 2020
A phase I-II design based on periodic and continuous monitoring of disease status and the times to toxicity and deathJuhee Lee, Peter F Thall, Pavlos MsaouelBiometrics|February 16, 2024
A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparisonYong Zang, Peter F Thall, Ying YuanStatistics in Medicine|October 12, 2021
Precision Bayesian phase I-II dose-finding based on utilities tailored to prognostic subgroupsJuhee Lee, Peter F Thall, Pavlos MsaouelStatistics in Biosciences|July 30, 2010
Evaluating the Impact of Prior Assumptions in Bayesian BiostatisticsSatoshi Morita, Peter F Thall, Peter MüllerPageof 20